Calamos Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Calamos Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$39.62 - $69.97 $1.17 Million - $2.07 Million	-29,571 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$58.09 - $82.51 $1.72 Million - $2.44 Million	29,571 New	29,571 $1.96 Million
Q2 2021 Jul 22, 2021	SELL	$62.15 - $90.32 $1.69 Million - $2.46 Million	-27,249 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$61.35 - $90.47 $1.06 Million - $1.56 Million	-17,220 Reduced 38.72%	27,249 $1.81 Million
Q4 2020 Jan 27, 2021	BUY	$43.82 - $85.37 $1.95 Million - $3.8 Million	44,469 New	44,469 $3.41 Million
Q1 2020 Apr 28, 2020	SELL	$20.56 - $63.12 $102,800 - $315,600	-5,000 Closed	0 $0
Q4 2019 Jan 15, 2020	SELL	$28.14 - $73.01 $168,840 - $438,060	-6,000 Reduced 54.55%	5,000 $317,000
Q3 2019 Oct 21, 2019	BUY	$26.26 - $34.86 $288,860 - $383,460	11,000 New	11,000 $310,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.